Skip to main content
Clinical Trials/NCT05450406
NCT05450406Not yet recruitingNot Applicable

The Inland Norway Healthy Life Center Study

Inland Norway University of Applied Sciences0 sites60 target enrollmentStarted: August 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Primary Endpoint
Maximal oxygen consumption (measured in mL/kg body mass/min)

Study Overview

Brief Summary

Healthy Life Centers (Norwegian, 'Frisklivssentralen') is a municipal service in Norway that aims to promote both physical and mental health, as well as to limit the development of non-communicable diseases. Previous research has shown that receiving follow-up from Healthy Life Centers has led to higher levels of daily physical activity, in addition to improved self-reported health and quality of life among the participants. However, there is a lack of studies that have examined what kind of physiological health effects can be expected from participating in the Healthy Life Center's follow-up.

In this study, responses to the 12-week physical activity program of the Healthy Life Center will be compared with the responses in a negative control group that does not receive such follow-up. Both the intervention group and the reference group (the negative control group) will carry out the same tests and measurements before and after the 12 week period. The tests will include measurements of anthropometric variables (body height, body weight and waist circumference), body composition, arterial stiffness, resting blood pressure and blood variables (blood glucose, long-term blood glucose, blood lipid profile and inflammation markers), in addition to physical tests of mobility, balance, maximum aerobic capacity (maximal oxygen consumption) and maximum muscle strength. Questionnaires related to adherence to the Healthy Life Center follow-up, socio-demographic variables, eating and drinking habits, activity level, perceived physical fitness, motivation for exercise, and health-related quality of life will also be included.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Intervention group
  • •Inclusion Criteria:
  • •>18 years of age
  • •Receiving follow-up from the Healthy Life Center

Exclusion Criteria

  • •In average >1 weekly exercise training session the last three months
  • •Reference group
  • •Inclusion Criteria:
  • •>18 years of age
  • •Exclusion Criteria:
  • •In average >1 weekly exercise training session the last three months
  • •Receiving follow-up from the Healthy Life Center

Arms & Interventions

Intervention group

Active Comparator

Participants in the intervention group will receive 12-week follow-up from the Healthy Life Center

Intervention: Physical activity (Other)

Control group

No Intervention

Participants in the intervention group will not receive follow-up from the Healthy Life Center

Outcomes

Primary Outcomes

Maximal oxygen consumption (measured in mL/kg body mass/min)

Time Frame: From before to after the 12-week intervention/control period

Difference in change between the two study arms from before to after the 12-week intervention/control period

Secondary Outcomes

  • Maximal muscle strength (measured in newtons produced during a leg press exercise)(From before to after the 12-week intervention/control period)
  • Maximal muscle power (measured in watts produced during a leg press exercise)(From before to after the 12-week intervention/control period)
  • Waist circumference(From before to after the 12-week intervention/control period)
  • Balance, measured using the "single leg stance test" (measured in seconds)(From before to after the 12-week intervention/control period)
  • Mobility, measured using the "sit-and-reach" and the "back stretch" test (measured in centimeters)(From before to after the 12-week intervention/control period)
  • Fat mass (measured in kilograms)(From before to after the 12-week intervention/control period)
  • Lean mass (measured in kilograms)(From before to after the 12-week intervention/control period)
  • Visceral fat (measured in grams)(From before to after the 12-week intervention/control period)
  • Cholesterol and total triglyceride levels (serum, fasted state)(From before to after the 12-week intervention/control period)
  • Health-related quality of life (measured using the SF-36 questionnaire; scores from 0-100, where a higher score means a better outcome)(From before to after the 12-week intervention/control period)
  • Body mass index(From before to after the 12-week intervention/control period)
  • Bone mineral density ( measured in g/cm2)(From before to after the 12-week intervention/control period)
  • Blood glucose levels (serum, fasted state)(From before to after the 12-week intervention/control period)
  • Resting blood pressure(From before to after the 12-week intervention/control period)
  • Systemic inflammation markers (levels of c-reactive protein, TNF-alpha, interleukin 6 and interleukin 8 in serum, fasted state)(From before to after the 12-week intervention/control period)
  • Arterial stiffness(From before to after the 12-week intervention/control period)

Investigators

Sponsor
Inland Norway University of Applied Sciences
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials